May 20, 2020Open Access

Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance

Key Points

Key points are not available for this paper at this time.

Abstract

T his is the second edition (version 1.2) of this document, which was originally adapted from Clinical management of severe acute respiratory infection when MERS-CoV infection is suspected (WHO, 2019).

Bookmark

View Full Paper

Cite This Study

World Health Organization (Wed,) studied this question.

synapsesocial.com/papers/6a1fd7ef0fcc66506a6f1284 https://doi.org/https://doi.org/10.15557/pimr.2020.0003

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records2020 · 698 citations
2Corticosteroids as adjunctive therapy in the treatment of influenza2013 · 21 citations
3Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure2017 · 1,617 citations
4Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis2019 · 400 citations
5Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial2018 · 543 citations

Bookmark

View Full Paper